Potent anti-leukemia activities of humanized CD19-targeted CAR-T cells in patients with relapsed/refractory acute lymphoblastic leukemia

被引:0
|
作者
Cao, J. [1 ]
Wang, G. [1 ]
Zheng, J. [1 ]
Xu, K. [1 ]
机构
[1] Xuzhou Med Univ, Xuzhou, Jiangsu, Peoples R China
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P1690
引用
收藏
页码:1719 / 1720
页数:2
相关论文
共 50 条
  • [1] Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia
    Cao, Jiang
    Wang, Gang
    Cheng, Hai
    Wei, Chen
    Qi, Kunming
    Sang, Wei
    Li Zhenyu
    Shi, Ming
    Li, Huizhong
    Qiao, Jianlin
    Pan, Bin
    Zhao, Jing
    Wu, Qingyun
    Zeng, Lingyu
    Niu, Mingshan
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 851 - 858
  • [2] Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia
    Wang, Shiyuan
    Wang, Xue
    Ye, Chunying
    Cheng, Hai
    Shi, Ming
    Chen, Wei
    Qi, Kunming
    Wang, Gang
    Wu, Qingyun
    Zeng, Lingyu
    Li, Zhenyu
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    Cao, Jiang
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E162 - E165
  • [3] Potent anti-leukemia activities of humanized chimeric antigen receptor modified T(CAR-T) cell therapy in Chinese patients with relapsed/refractory acute lymphoblast leukemia
    Xiao, Lei
    Zhang, Qing
    Zhu, Xiaofan
    Wu, Zhao
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 233 - 233
  • [4] A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia
    DasGupta, Ryan K.
    Marini, Bernard L.
    Rudoni, Joslyn
    Perissinotti, Anthony J.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : 453 - 467
  • [5] Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Maude, Shannon L.
    Barrett, David M.
    Rheingold, Susan R.
    Aplenc, Richard
    Teachey, David T.
    Callahan, Colleen
    Baniewicz, Diane
    White, Claire
    Talekar, Mala K.
    Shaw, Pamela A.
    Brogdon, Jennifer L.
    Young, Regina M.
    Scholler, John
    Marcucci, Katherine T.
    Levine, Bruce L.
    Frey, Noelle
    Porter, David L.
    Lacey, Simon F.
    Melenhorst, J. Joseph
    June, Carl H.
    Grupp, Stephan A.
    [J]. BLOOD, 2016, 128 (22)
  • [6] CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
    Davila, Marco L.
    Brentjens, Renier J.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (10) : 802 - 808
  • [7] Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Myers, Regina M.
    Li, Yimei
    Leahy, Allison Barz
    Barrett, David M.
    Teachey, David T.
    Callahan, Colleen
    Fasano, Christina C.
    Rheingold, Susan R.
    DiNofia, Amanda
    Wray, Lisa
    Aplenc, Richard
    Baniewicz, Diane
    Liu, Hongyan
    Shaw, Pamela A.
    Pequignot, Edward
    Getz, Kelly D.
    Brogdon, Jennifer L.
    Fesnak, Andrew D.
    Siegel, Donald L.
    Davis, Megan M.
    Bartoszek, Chelsie
    Lacey, Simon F.
    Hexner, Elizabeth O.
    Chew, Anne
    Wertheim, Gerald B.
    Levine, Bruce L.
    June, Carl H.
    Grupp, Stephan A.
    Maude, Shannon L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (27) : 3044 - +
  • [8] CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).
    Newman, Haley
    Leahy, Allison Emily Barz
    Li, Yimei
    Liu, Hongyan
    Myers, Regina M.
    DiNofia, Amanda M.
    Dolan, Joseph Gregory
    Callahan, Colleen
    Devine, Kaitlin J.
    Wray, Lisa
    June, Carl H.
    Grupp, Stephan A.
    Rheingold, Susan R.
    Maude, Shannon L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia
    Hu, Yongxian
    Wu, Zhao
    Luo, Yi
    Shi, Jimin
    Yu, Jian
    Pu, Chengfei
    Liang, Zuyu
    Wei, Guoqing
    Cui, Qu
    Sun, Jie
    Jiang, Jing
    Xie, Jue
    Tan, Yamin
    Ni, Wanmao
    Tu, Jifang
    Wang, Jinping
    Jin, Aiyun
    Zhang, Hao
    Cai, Zhen
    Xiao, Lei
    Huang, He
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (13) : 3297 - 3306
  • [10] Humanized CD19-directed CAR-T Cell Therapy in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia With CNSL or Neurological Comorbidity
    Zhang, Na
    Shao, Jingbo
    Li, Hong
    Zhu, Jiashi
    Xia, Min
    Chen, Kai
    Jiang, Hui
    [J]. JOURNAL OF IMMUNOTHERAPY, 2022, 45 (09) : 396 - 406